Vir Biotechnology, Inc. (VIR)
6.66
+0.08
(+1.22%)
USD |
NASDAQ |
Dec 09, 16:00
6.665
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Shareholders Equity (Quarterly): 796.10M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | 66.34M |
| Bristol Myers Squibb Co. | 18.55B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.019B |
| Total Liabilities (Quarterly) | 223.36M |
| Debt to Equity Ratio | 0.1258 |
| Current Ratio | 7.254 |
| Net Debt Paydown Yield | 0.36% |